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Abstract Recent advancements in transnasal endoscopy
enable a shift in diagnostic workup of lesions in the
pharynx and larynx, from an examination with biopsy
under general anesthesia to an office-based examination
with flexible endoscopic biopsy under topical anesthesia.
Procedural complications were evaluated to assess the
safety of office-based flexible endoscopic biopsy in patients
with benign and malignant laryngopharyngeal lesions.
Patients who underwent flexible endoscopic biopsy from
2012 to 2016 were evaluated retrospectively. Complica-
tions were classified using the Clavien–Dindo classification
of surgical complications. A total of 201 flexible endo-
scopic biopsies were performed in 187 patients. Two Cla-
vien–Dindo grade I (laryngospasm and anterior epistaxis),
one grade II (laryngeal bleeding), and one grade IIIb (la-
ryngeal edema) complication were observed. The first
complication was self-limiting and the other three required
an intervention. All patients fully recovered without
sequelae. Flexible endoscopic biopsy appears to be a safe
office-based procedure for the diagnosis of benign and
malignant laryngopharyngeal lesions.
Keywords Flexible endoscopic biopsy  Laryngeal
biopsy  Office-based biopsy  In-office biopsy  Office-
based procedures  Local anesthesia
Introduction
Head and neck cancer is the fifth most common cancer in
the world [1]. The estimated incidence of nasopharyngeal,
oropharyngeal, hypopharyngeal, and laryngeal (i.e., laryn-
gopharyngeal) cancers worldwide was approximately
385,000 new cases in 2012 with over 230,000 estimated
deaths [1]. In The Netherlands, approximately 1565 new
cases of laryngopharyngeal cancer were diagnosed in 2015
[2].
The early diagnosis is crucial for improving the treat-
ment results of laryngopharyngeal cancer [3]. It increases
survival and the chance of preserving laryngeal function
[4]. Diagnostic assessment aims at histological diagnosis,
mapping, and staging of the tumor [3]. The initial work-up
starts with a history, physical examination, and imaging
[5]. However, a biopsy is essential for the histological
diagnosis of laryngopharyngeal cancer [3]. Traditionally,
the biopsy of laryngopharyngeal lesions is performed under
general anesthesia. Technological advancements in the
types of transnasal endoscopes, instrument miniaturization,
and topical anesthetic techniques have led to a shift in
laryngeal management from the operation room to an
office-based setting [6–8]. Since the introduction of
fiberoptic laryngoscopy in the 1970s, lighting and imaging
techniques have improved substantially [9]. During the last
decade, fiberoptic endoscopy has gradually been replaced
by distal chip endoscopy [10, 11]. In the latter, information
from a chip in the distal tip of the endoscope is send to a
video processor, which creates a digital image and enables
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high-resolution imaging. Furthermore, endoscopes can be
equipped with a built in working channel for passage of a
flexible biopsy forceps or a laser fiber [6, 8, 10]. This
enables clinicians to perform surgical procedures under
topical anesthesia in an office-based setting, such as laser
surgery or flexible endoscopic biopsy (FEB).
Office-based laryngeal FEB is reported to be safe
[6, 12–14], feasible [6], cost-effective [12, 15], and easy to
perform [13, 16]. The advantages are an awake patient who
is sitting in an upright position and able to control laryngeal
function during the procedure, which can result in adequate
visualization of the designated lesion [10]. Furthermore,
there is avoidance of general anesthesia with possible
health benefits [14, 17]. Its costs are relatively low com-
pared with examination and biopsy under general anes-
thesia [12, 15]. Most importantly, FEB can often be
performed during the initial outpatient visit or follow-up
visit, which results in reduced diagnostic delay [7, 18]. An
additional advantage of digital endoscopic techniques is the
possibility of recording images, enabling more detailed
reporting in the patient’s electronic file and comparison of
images during follow-up. The disadvantages of laryngeal
FEB are the need for a cooperative patient (e.g., able to sit
still, minimal gag reflex) [8] and the inability to perform
deep biopsies of submucosal tumors [12].
Due to the relative novelty of this office-based proce-
dure, few studies are available and complication rates have
been assessed in small sample sizes [6, 7, 12–14, 19].
Therefore, the aim of this study was to investigate the
complications of transnasal FEB under topical anesthesia
in patients with benign and malignant laryngopharyngeal
lesions. This study provides a more detailed insight into the
safety of the procedure. To assess safety, complications
were evaluated using the Clavien–Dindo classification,
which is an objective scoring system for classifying com-
plications and is also reproducible [20]. To our knowledge,
the investigated study population is the largest in the
literature.
Materials and methods
Patient selection
This retrospective cohort study was conducted from April
2012 to April 2016 at the Department of Otorhinolaryn-
gology and Head and Neck Surgery of the Radboud
University Medical Center in Nijmegen, The Netherlands.
Eligible study participants were patients aged 18 years or
older who underwent transnasal FEB under topical anes-
thesia for benign or malignant laryngopharyngeal lesions.
Anticoagulant (i.e., thrombocyte aggregation inhibitors,
adenosine diphosphate receptor inhibitors, and vitamin K
antagonists) use was not considered a contraindication.
Submucosal lesions or lesions with undefined tumor mar-
gins visualized during diagnostic flexible laryngoscopy
were excluded. These patients were excluded, because the
FEB procedure was performed not only to obtain a histo-
logical diagnosis, but also to provide information on tumor
size and stage. Patients who underwent multiple biopsies
for recurrent lesions or for two separate suspected laryn-
gopharyngeal lesions were included twice.
Diagnostic work-up
In this study, FEB was the first choice for diagnostic work-
up of benign and malignant laryngopharyngeal lesions, as
shown in Fig. 1. Patients visiting the outpatient clinic of
our department usually receive FEB the same day. As all
other diagnostic (imaging) procedures are performed
within 2 days and the results of histological and cytological
examination are available within 1 day, each case can be
discussed in the multidisciplinary head and neck oncology
tumor board meeting after 2 days. The histology result of
laryngeal FEB was positive for malignancy (i.e., malignant
result), negative for malignancy (i.e., nonmalignant result),
or non-diagnostic. A non-diagnostic result could occur
when it was impossible to obtain a biopsy specimen or
when no histological diagnosis could be determined in case
of superficially obtained tissue [15]. In the case of an
established malignancy, the treatment could be determined
by the multidisciplinary tumor board immediately. In
contrast, nonmalignant results of FEB were interpreted
with caution. In case of an inconsistency with the clinical
findings (i.e., appearance suspicious for malignancy), FEB
was repeated or an examination with biopsy under general
anesthesia was performed. If a nonmalignant result of FEB
that was consistent with the clinical findings was obtained,
the patient proceeded to follow-up according to protocol.
Biopsy technique
After acquiring informed consent from the patients, FEB
was performed in an examination room at the outpatient
clinic department. Prior to biopsy, topical anesthesia was
administered using two cotton pledgets and soaked in 10%
lidocaine spray and 0.1% xylometazoline solution, which
were placed in each side of the nasal cavity for a minimum
of 10 min. The pharynx and larynx were sprayed with 10%
lidocaine spray transorally, immediately after nasal anes-
thesia and just prior to the procedure. The number of sprays
varied between 8 and 14. In case of a laryngeal biopsy,
additional anesthesia was performed by intratracheal
injection of 1.0 ml of 10% lidocaine through the
cricothyroid membrane and topical administration on the
vocal cords.
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Biopsies were obtained using a flexible video endoscope
with a 2.0 mm diameter working channel (VNL-1570STK,
Pentax Medical, Japan) and a single-use 1.8 mm diameter
flexible biopsy forceps (Radial JawTM 4, Boston Scientific,
Costa Rica). Images were displayed and recorded using a
video processor (EPK-i5000, Pentax Medical, Japan).
During biopsy, the flexible video endoscope was inserted
transnasally in patients in a sitting position. After visual-
ization of the laryngopharyngeal lesion, a biopsy forceps
was passed through the working channel. The lesion was
approached with an open jaw biopsy forceps, pushed deep
into the lesion, and closed. The biopsy forceps was pulled
back swiftly, while feeling for resistance when removing
the tissue from the suspected lesion, which indicates a
deeply taken biopsy. If possible, three deep biopsies were
taken from each suspected lesion. All biopsies were per-
formed by two physicians, either head and neck surgeons
or senior residents under direct supervision.
Data collection and analysis
Data were collected on patient characteristics (i.e., sex,
age, anticoagulation use, biopsy site, and definitive histo-
logical diagnosis) and complications. A complication was
defined as any deviation from the normal course after the
performance of a FEB procedure [20]. To minimize sub-
jectivity in the reporting of complications, terms such as
‘minor’, ‘major’, ‘mild’, or ‘severe’ were avoided. Instead,
the Clavien–Dindo classification of surgical complications
was used [20]. Statistical analysis was performed using
IBM Statistical Package for Social Sciences Statistics 22
(IBM Corp. Released 2013. IBM SPSS Statistics for
Windows, Version 22.0. Armonk, NY: IBM Corp).
Results
Two hundred and one transnasal FEB procedures in 187
patients were included with 561 obtained biopsies, result-
ing in an average of 2.8 biopsies per procedure. There were
14 double inclusions, of which 13 were due to suspected
recurrent lesions and one patient had two separate tumors
that required FEB.
Patient characteristics are shown in Table 1. The study
population consisted mostly of men (78.6%) of older age
(mean 66.8 years). Almost one-third of patients used
anticoagulants (29.9%). The most common biopsy site was
the larynx with 138 biopsies (68.7%). Definitive histology
results were squamous cell carcinoma in over half of the
cases (57.2%) and severe dysplasia or carcinoma in situ in
over one-fifth of the cases (21.4%). One histology result
showed a lymphoma. In 5 out of 201 procedures, it was
impossible to obtain a biopsy specimen. In one patient, the
flexible endoscope could not be passed through the nose
due to the small nasal anatomy of the patient; in two
patients, a complication occurred during biopsy and the
procedure, therefore, had to be aborted (i.e., laryngeal
bleeding and supraglottic edema); in two cases, the patient
could not tolerate the procedure (e.g., excessive coughing
or pharyngeal reflex). In 1 out of 201 FEB procedures,
histological classification could not be determined by the
pathologist because of superficial biopsy specimens.
In 201 FEB procedures that were performed in this
study, four patients had complications. Complications were
laryngospasm, anterior epistaxis, laryngeal bleeding, and
supraglottic edema; using the Clavien–Dindo classification
system, these complications could be defined as two grade I
(laryngospasm and anterior epistaxis), one grade II (la-
ryngeal bleeding), and one grade IIIb (supraglottic edema)
complication, respectively. The laryngospasm was self-
limiting, while the other complications required an inter-
vention. All complications resolved without sequelae.
Case 1: Laryngospasm
A 61-year-old man was referred to us with a neck metas-
tasis from an unknown primary tumor. During diagnostic
flexible laryngoscopy, a small ulcerative lesion was
observed on the laryngeal side of the epiglottis. The patient
underwent a FEB, and after the first biopsy, laryngospasm
Fig. 1 Flowchart of flexible endoscopic biopsy
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with stridor occurred. The patient was attended in the
outpatient clinic and the symptoms were self-limiting. No
further biopsies were performed. The patient underwent an
examination under general anesthesia that did not reveal a
malignancy. The tumor was defined as an unknown pri-
mary and the patient underwent treatment according to
protocol.
Case 2: Anterior epistaxis
A 63-year-old woman underwent a FEB for a suspicious
lesion in the vallecula with extension up to the epiglottis.
After the first biopsy, the patient developed anterior epis-
taxis. Intranasal cotton pledgets soaked in 0.1% xylometa-
zoline were placed in the right nostril. The anterior epistaxis
stopped and three more biopsies were performed.
Case 3: Laryngeal bleeding
A 73-year-old woman was diagnosed with an intubation
granuloma, which she developed after surgery 2 months
earlier. During examination under general anesthesia,
adequate visualization of the intubation granuloma was not
possible because of the small mandibular space and limited
retroflexion of the neck. Therefore, a FEB was scheduled.
After injecting topical anesthesia through the cricothyroid
membrane of the glottic region, hemoptysis occurred.
There were no symptoms of dyspnea or stridor. Nebulized
adrenalin and xylometazoline were ineffective, but the
laryngeal bleeding stopped after subcutaneous injection of
0.5 mg of adrenalin around the cricothyroid membrane.
The patient had an overnight observation in the hospital.
On follow-up 4 weeks later, spontaneous regression of the
intubation granuloma was observed during flexible
laryngoscopy.
Case 4: Subglottic edema
A 83-year-old man with a medical history of chronic
obstructive pulmonary disease and Alzheimer’s disease
was referred by the general practitioner to our hospital
because of hoarseness and increasing dyspnea. Treatment
with inhalation corticosteroids was started because of
suspicion of an exacerbation of the chronic obstructive
pulmonary disease. At flexible laryngoscopy, a large
bilateral glottic tumor was observed. After taking the first
biopsy, the patient experienced a strong pharyngeal reflex
and started coughing vigorously. Additional topical anes-
thesia was administered and the procedure was temporarily
paused. It was not possible to proceed with the FEB
because of coughing, and the patient was dismissed from
the hospital without additional complaints.
The same evening, the patient was admitted to the
emergency department with increasing dyspnea and
laryngeal edema was seen during flexible laryngoscopy. He
was repeatedly nebulized with 30 ml of salbutamol/iprat-
ropium at 0.1/1.0 mg and administered 0.5 mg adrenalin
intravenously. The effect was insufficient, and the patient
underwent a tracheotomy in the operation room with
biopsies the next day, which histologically showed squa-
mous cell carcinoma of the vocal cords.
Table 1 Patient characteristics
of laryngopharyngeal flexible
endoscopic biopsy
Characteristics Flexible endoscopic biopsy %
Study population 201 100
Sex (number males) 158 78.6
Age (range) 66.8 (43–92)
Anticoagulant use (no) 60 29.9
Site biopsy
Nasopharynx (no) 5 2.5
Oropharynx (no) 36 17.9
Hypopharynx (no) 19 9.5
Larynx (no) 138 68.7
Neopharynx (no) 3 1.5
Definitive histology
Benign (no) 5 2.5
Hyperplasia 24 11.9
Mild/moderate dysplasia 7 3.5
Severe dysplasia/carcinoma in situ 43 21.4
Squamous cell carcinoma (no) 115 57.2
Lymphoma (no) 1 0.5
No histology result (no) 6 3.0
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Discussion
In the last decade, technological advancements have
caused a shift in the evaluation of most laryngopharyngeal
lesions from the operating room to an office-based setting
[6, 8]. However, before a diagnostic method is imple-
mented in clinical practice, several factors need to be
considered [14]. First, the safety of office-based FEB for
laryngopharyngeal lesions has to be determined. The cur-
rent study showed that four complications occurred out of
201 FEB procedures, and each complication did not occur
twice. Thus, the incidence was 0.5% for each complication.
A few studies reported on the safety of FEB for laryn-
gopharyngeal lesions, showing low complication rates
[6, 7, 12–14]. Cohen et al. reported three complications in
112 patients, including ‘‘a post-procedure aspiration in one
patient (without serious consequences) and a self-limited
epistaxis in two patients’’ [13]. Further description, for
example, on the intervention or outcome of these compli-
cations, was not provided by the authors. Lippert et al.
assessed the safety of FEB in 24 transoral and 76 transnasal
procedures [14]. No complications were reported and no
association was observed with procedure tolerance or
biopsy approach. Three other articles, with patient numbers
varying from 12 to 76 patients, reported no complications
during FEB [6, 7, 12].
To our knowledge, this is currently the largest study
cohort for FEB reported in the literature. Furthermore,
complications were systematically identified and classified
according to a validated protocol. The results of the current
study are in line with those of previous studies regarding
the complications of FEB for laryngopharyngeal lesions,
and showed four complications in a total of 201 proce-
dures. Grade I and II complications, anterior epistaxis and
laryngeal bleeding, demanded intervention as well as the
grade IIIb complication of supraglottic edema. The grade I
complication of laryngospasm was self-limiting. It is
important to note that all complications recovered without
sequelae. The case of supraglottic edema resulted in a
tracheostomy, which was reversed approximately 2 weeks
later.
Contraindications are an important consideration in any
surgical procedure. In this study, a patient with a com-
promised airway was considered an absolute contraindi-
cation, which is in agreement with the reported literature
[7]. In retrospect, the fourth case may not have had a
compromised airway during biopsy, but he did have a
compromised airway, which required a tracheotomy, when
he was admitted to the emergency department. In some
studies, anticoagulant use was considered a relative con-
traindication; patients were advised to stop anticoagulation
use, defer the procedure, or they were excluded from
further analysis [6, 7, 14, 15]. In the current study, anti-
coagulant use was not considered a contraindication and it
was reported in 29.9% of the patients who underwent FEB.
One of four patients (25%) with a complication in this
cohort used anticoagulants but did not develop bleeding.
Although care should be taken in patients who use anti-
coagulants, we believe that this should not be a factor that
prevents a FEB under topical anesthesia.
A limitation of this study was the retrospective study
design. Furthermore, there was a possibility of selection
bias, and some complications may have developed after the
outpatient clinic visit, which might not be included in this
study. In addition, the physician judged whether a patient
could cooperate in FEB under topical anesthesia. This is a
subjective measure and it, therefore, might differ between
physicians. It is important to note that this would occur less
often with more experience gained with the number of
laryngeal FEB procedures performed and local anesthetic
techniques.
Conclusion
In this study, FEB for laryngopharyngeal lesions showed
low complication rates and we thus conclude that the
performance of FEB under topical anesthesia is safe for the
histological diagnosis of benign and malignant laryn-
gopharyngeal lesions. These results can contribute to a
wider understanding of the possible complications that can
occur during FEB and help guide physicians when FEB is
first performed in the outpatient clinic.
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